Sponsor pipeline

HeartFlow, Inc. clinical trial pipeline

Get alerts when HeartFlow, Inc.'s trials change

5 active trials 2 recruiting 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-10-02 NCT07853716 REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is… Not Yet Recruiting
2026-09-22 NCT07834372 REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve… Not Yet Recruiting

Active trials by phase

Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Not applicable
NCT07853716 REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is… CAD - Coronary Artery Disease Not Yet Recruiting 2026-10-02
NCT07834372 REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve… CAD - Coronary Artery Disease Not Yet Recruiting 2026-09-22
Not specified
NCT07479433 The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting… Coronary Artery Disease (CAD) Recruiting 2026-03-23
NCT06831409 Using CTA Measures to Define Cardiac Risk In NFL Alumni Coronary Artery Disease (CAD) Recruiting 2025-08-26
NCT06376851 AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD… Coronary Artery Disease Active, Not Recruiting 2026-09-15

Disease areas by active trials

Coronary Artery Disease (5) · Heart Disease (1)

Get alerts when HeartFlow, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free